Clinical trial
Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00427414 · AIDS Malignancy Consortium, Other · Terminated
Key facts
| NCT number | NCT00427414 |
|---|---|
| Title | Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma |
| Official title | Pilot Study of Viral Load and Transcription in Kaposi's Sarcoma Patients Treated With Liposomal Anthracyclines |
| Lead sponsor | AIDS Malignancy Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH The Emmes Company, LLC Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | liposomal daunorubicin citrate |
| Enrollment | 14 |
| Start date | Sep 1, 2008 |
| Primary completion | Nov 1, 2010 |
| Completion | Nov 1, 2011 |
| First posted | Jan 29, 2007 |
| Last update posted | Apr 29, 2015 |
| Countries | Brazil, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: